Breaking News
Get 45% Off 0
🤖 Are you in? These 5 AI-picked stocks are up 15%+
Read article

Stock Markets Analysis & Opinion

Contribute
Zacks Investment Research
Volkswagen's Core Auto Sale Reaches Record High In 2017 By Zacks Investment Research - Jan 15, 2018

Per Reuters, Volkswagen (DE:VOWG_p) AG’s (OTC:VLKAY) core auto division has achieved record-high sales in 2017, primarily on higher demand for the company’s major brand models in the...

Zacks Investment Research
Prothena (PRTA) Tumbles 18% In A Year: What Lies Ahead? By Zacks Investment Research - Jan 15, 2018

Shares of Prothena Corporation (NASDAQ:PRTA) lost 18.1% over a year as against the industry’ gain of 3.1%. The company suffered a setback in 2017 when the company decided not to continue with...

Zacks Investment Research
Here's Why Koppers (KOP) Should Be In Your Portfolio Now By Zacks Investment Research - Jan 15, 2018

Koppers Holdings Inc.’s (NYSE:KOP) stock looks promising at the moment. The company has seen its shares rally roughly 30% over the past six months, outperforming its industry’s...

Zacks Investment Research
Buy These 5 Price-to-Book Value Stocks In 2018 For Gains By Zacks Investment Research - Jan 15, 2018

Value investors have, over the years, preferred price-to-earnings ratio or P/E as a means to identify value stocks. However, in case of loss-making companies that have a negative Price-to-Earnings...

Zacks Investment Research
5 Top-Ranked Stocks To Pick On DuPont Theory By Zacks Investment Research - Jan 15, 2018

Return on equity (ROE) is one of the most-favored metrics of investors. It is a profitability ratio that measures earnings generated by a company from its equity. Investors can follow the ROE trend in...

Zacks Investment Research
3 Strong Buy Schwab Mutual Funds For Marvelous Returns By Zacks Investment Research - Jan 15, 2018

Founded in 1989, Charles Schwab (NYSE:SCHW) Investment Management, Inc. provides diverse investment products to its clients, including institutional and private investors. Charles Schwab...

Zacks Investment Research
Roche MS Drug Ocrevus Gets Marketing Authorization In Europe By Zacks Investment Research - Jan 15, 2018

Roche Holdings (OTC:RHHBY) announced that the European Commission (EC) has granted marketing authorization for multiple sclerosis (MS) drug Ocrevus.The drug is approved for patients suffering from...

Candy Matheson
Will U.S. Banks Outperform The S&P 500 Index In 2018? By Candy Matheson - Jan 15, 2018

The following monthly chart of the Financial Sector (Financial Select Sector SPDR (NYSE:XLF)) shows that it has been on a strong rally since mid-2017. It's approaching major resistance around the...

Candy Matheson
Will GE Ever Recover? By Candy Matheson - Jan 15, 2018

General Electric Company (NYSE:GE) looks to be in trouble, as it has failed to hold onto gains made after the 2008/09 financial crisis and has fallen well below longer-term major support.However, it...

Zacks Investment Research
New Study Links Price Manipulation To Bitcoin's Insane Surge By Zacks Investment Research - Jan 15, 2018

Is it possible that suspicious activity from just one person could have caused a 566% surge in the price of bitcoin? Well, according to a new study published in the Journal of Monetary Economics, the...

Zacks Investment Research
Here???s Why You Should Avoid Betting On REITs For Now By Zacks Investment Research - Jan 15, 2018

In the latest FOMC meeting, the benchmark interest rate was hiked by a quarter point and three more rate hikes were flagged for the current year. So obviously, betting on REIT stocks could be risky in...

Zacks Investment Research
Treasury ETFs In Focus As Yields Rise By Zacks Investment Research - Jan 15, 2018

Inflation in the United States seems to be rebounding. Moreover, U.S. equities have been rallying on strong economic fundamentals, leading to an increase in investors’ risk appetite and...

Continue with Apple
Continue with Google
or
Sign up with Email